Why would there be new data? It hasn't advanced to Ph3 which require 100s of patients so will cost a lot more money and time. The study demonstrate the benefit of using HER-Vaxx in chemotherapy for patient with advanced gastric cancer and if they can advance this to other cancer then the IP will be worth more. It measure Overall and Progression Free Survival as chemotherapy is the last resort for extension of life in specific cancer which reached incurable stage.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)